ARTICLE | Company News
BioVeris, Children's Hospital & Research Center at Oakland deal
October 25, 2004 7:00 AM UTC
BIOV received an exclusive option from the hospital to a vaccine candidate against Neisseria meningitides serogroup B, which causes meningitis. BIOV will provide the hospital with up to $800,000 in re...